Bristol-Myers Squibb Company Ce (CELG-RI)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 38.18 Billion USD | 5.14% |
| 2022 | 36.31 Billion USD | -10.28% |
| 2021 | 40.47 Billion USD | -17.67% |
| 2020 | 49.16 Billion USD | 11.6% |
| 2019 | 44.05 Billion USD | 680.36% |
| 2018 | 5.64 Billion USD | -19.05% |
| 2017 | 6.97 Billion USD | 22.03% |
| 2016 | 5.71 Billion USD | -12.73% |
| 2015 | 6.55 Billion USD | -9.56% |
| 2014 | 7.24 Billion USD | -9.26% |
| 2013 | 7.98 Billion USD | 21.51% |
| 2012 | 6.56 Billion USD | 22.17% |
| 2011 | 5.37 Billion USD | 0.9% |
| 2010 | 5.32 Billion USD | -13.08% |
| 2009 | 6.13 Billion USD | -6.91% |
| 2008 | 6.58 Billion USD | 50.31% |
| 2007 | 4.38 Billion USD | -39.56% |
| 2006 | 7.24 Billion USD | -13.34% |
| 2005 | 8.36 Billion USD | -1.17% |
| 2004 | 8.46 Billion USD | -0.69% |
| 2003 | 8.52 Billion USD | 36.11% |
| 2002 | 6.26 Billion USD | 0.38% |
| 2001 | 6.23 Billion USD | 366.84% |
| 2000 | 1.33 Billion USD | -0.45% |
| 1999 | 1.34 Billion USD | -1.61% |
| 1998 | 1.36 Billion USD | 6.65% |
| 1997 | 1.27 Billion USD | 32.4% |
| 1996 | 966 Million USD | 52.13% |
| 1995 | 635 Million USD | -1.4% |
| 1994 | 644 Million USD | 9.52% |
| 1993 | 588 Million USD | 234.09% |
| 1992 | 176 Million USD | 30.37% |
| 1991 | 135 Million USD | -41.56% |
| 1990 | 231 Million USD | -2.53% |
| 1989 | 237 Million USD | -16.55% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 48.85 Billion USD | -1.27% |
| 2024 Q1 | 51.05 Billion USD | 35.01% |
| 2024 Q3 | 48.67 Billion USD | -0.38% |
| 2023 Q3 | 33.65 Billion USD | -6.52% |
| 2023 Q2 | 35.99 Billion USD | -1.23% |
| 2023 Q1 | 36.44 Billion USD | 0.36% |
| 2023 FY | 38.18 Billion USD | 5.14% |
| 2023 Q4 | 38.18 Billion USD | 13.47% |
| 2022 FY | 36.31 Billion USD | -10.28% |
| 2022 Q1 | 38.3 Billion USD | -5.38% |
| 2022 Q2 | 37.92 Billion USD | -0.99% |
| 2022 Q3 | 37.81 Billion USD | -0.29% |
| 2022 Q4 | 36.31 Billion USD | -3.95% |
| 2021 Q1 | 45.33 Billion USD | -7.8% |
| 2021 FY | 40.47 Billion USD | -17.67% |
| 2021 Q4 | 40.47 Billion USD | -0.31% |
| 2021 Q3 | 40.6 Billion USD | -6.58% |
| 2021 Q2 | 43.46 Billion USD | -4.12% |
| 2020 Q3 | 42.08 Billion USD | -1.1% |
| 2020 Q4 | 49.16 Billion USD | 16.83% |
| 2020 FY | 49.16 Billion USD | 11.6% |
| 2020 Q1 | 43.53 Billion USD | -1.2% |
| 2020 Q2 | 42.55 Billion USD | -2.24% |
| 2019 FY | 44.05 Billion USD | 680.36% |
| 2019 Q4 | 44.05 Billion USD | 80.64% |
| 2019 Q1 | 5.63 Billion USD | -0.19% |
| 2019 Q2 | 24.43 Billion USD | 333.59% |
| 2019 Q3 | 24.39 Billion USD | -0.18% |
| 2018 Q3 | 5.68 Billion USD | 0.28% |
| 2018 FY | 5.64 Billion USD | -19.05% |
| 2018 Q4 | 5.64 Billion USD | -0.72% |
| 2018 Q2 | 5.67 Billion USD | -1.8% |
| 2018 Q1 | 5.77 Billion USD | -17.2% |
| 2017 Q3 | 6.98 Billion USD | 1.03% |
| 2017 Q2 | 6.91 Billion USD | -4.5% |
| 2017 Q1 | 7.23 Billion USD | 26.61% |
| 2017 FY | 6.97 Billion USD | 22.03% |
| 2017 Q4 | 6.97 Billion USD | -0.1% |
| 2016 Q4 | 5.71 Billion USD | -2.06% |
| 2016 FY | 5.71 Billion USD | -12.73% |
| 2016 Q1 | 6.59 Billion USD | 0.66% |
| 2016 Q2 | 6.58 Billion USD | -0.18% |
| 2016 Q3 | 5.83 Billion USD | -11.32% |
| 2015 Q4 | 6.55 Billion USD | -1.24% |
| 2015 Q1 | 7.12 Billion USD | -1.59% |
| 2015 Q3 | 6.63 Billion USD | 0.26% |
| 2015 Q2 | 6.61 Billion USD | -7.18% |
| 2015 FY | 6.55 Billion USD | -9.56% |
| 2014 FY | 7.24 Billion USD | -9.26% |
| 2014 Q2 | 7.37 Billion USD | 0.07% |
| 2014 Q1 | 7.36 Billion USD | -7.69% |
| 2014 Q3 | 7.26 Billion USD | -1.42% |
| 2014 Q4 | 7.24 Billion USD | -0.34% |
| 2013 Q2 | 6.44 Billion USD | -1.23% |
| 2013 Q4 | 7.98 Billion USD | 22.18% |
| 2013 Q3 | 6.53 Billion USD | 1.4% |
| 2013 Q1 | 6.52 Billion USD | -0.7% |
| 2013 FY | 7.98 Billion USD | 21.51% |
| 2012 Q2 | 5.2 Billion USD | -1.16% |
| 2012 Q3 | 6.6 Billion USD | 26.86% |
| 2012 Q4 | 6.56 Billion USD | -0.61% |
| 2012 FY | 6.56 Billion USD | 22.17% |
| 2012 Q1 | 5.27 Billion USD | -1.97% |
| 2011 Q2 | 5.33 Billion USD | 1.06% |
| 2011 Q4 | 5.37 Billion USD | -1.12% |
| 2011 Q3 | 5.43 Billion USD | 1.97% |
| 2011 FY | 5.37 Billion USD | 0.9% |
| 2011 Q1 | 5.27 Billion USD | -0.98% |
| 2010 Q1 | 6.08 Billion USD | -0.8% |
| 2010 FY | 5.32 Billion USD | -13.08% |
| 2010 Q4 | 5.32 Billion USD | -17.77% |
| 2010 Q3 | 6.47 Billion USD | 3.7% |
| 2010 Q2 | 6.24 Billion USD | 2.75% |
| 2009 Q4 | 6.13 Billion USD | -2.81% |
| 2009 Q1 | 6.49 Billion USD | -1.41% |
| 2009 FY | 6.13 Billion USD | -6.91% |
| 2009 Q3 | 6.3 Billion USD | 1.15% |
| 2009 Q2 | 6.23 Billion USD | -3.96% |
| 2008 Q2 | 6.02 Billion USD | 29.21% |
| 2008 Q3 | 6.12 Billion USD | 1.64% |
| 2008 FY | 6.58 Billion USD | 50.31% |
| 2008 Q4 | 6.58 Billion USD | 7.6% |
| 2008 Q1 | 4.66 Billion USD | 6.37% |
| 2007 FY | 4.38 Billion USD | -39.56% |
| 2007 Q3 | 4.24 Billion USD | -39.12% |
| 2007 Q1 | 7.13 Billion USD | -1.6% |
| 2007 Q4 | 4.38 Billion USD | 3.13% |
| 2007 Q2 | 6.97 Billion USD | -2.16% |
| 2006 Q2 | 8.23 Billion USD | -0.47% |
| 2006 FY | 7.24 Billion USD | -13.34% |
| 2006 Q1 | 8.27 Billion USD | -1.03% |
| 2006 Q3 | 7.83 Billion USD | -4.88% |
| 2006 Q4 | 7.24 Billion USD | -7.52% |
| 2005 Q1 | 8.32 Billion USD | -1.62% |
| 2005 FY | 8.36 Billion USD | -1.17% |
| 2005 Q4 | 8.36 Billion USD | 41.88% |
| 2005 Q3 | 5.89 Billion USD | -1.88% |
| 2005 Q2 | 6 Billion USD | -27.84% |
| 2004 Q4 | 8.46 Billion USD | -0.9% |
| 2004 Q1 | 8.63 Billion USD | 1.33% |
| 2004 Q2 | 8.37 Billion USD | -3.0% |
| 2004 Q3 | 8.54 Billion USD | 1.96% |
| 2004 FY | 8.46 Billion USD | -0.69% |
| 2003 Q2 | 6.42 Billion USD | 0.86% |
| 2003 Q3 | 7.42 Billion USD | 15.56% |
| 2003 Q1 | 6.36 Billion USD | 1.69% |
| 2003 Q4 | 8.52 Billion USD | 14.84% |
| 2003 FY | 8.52 Billion USD | 36.11% |
| 2002 FY | 6.26 Billion USD | 0.38% |
| 2002 Q3 | 6.2 Billion USD | 1.04% |
| 2002 Q4 | 6.26 Billion USD | 0.92% |
| 2002 Q1 | 6.17 Billion USD | -1.07% |
| 2002 Q2 | 6.14 Billion USD | -0.49% |
| 2001 Q4 | 6.23 Billion USD | -0.35% |
| 2001 Q2 | 1.3 Billion USD | -1.06% |
| 2001 FY | 6.23 Billion USD | 366.84% |
| 2001 Q3 | 6.25 Billion USD | 380.72% |
| 2001 Q1 | 1.31 Billion USD | -1.5% |
| 2000 FY | 1.33 Billion USD | -0.45% |
| 2000 Q4 | 1.33 Billion USD | 0.98% |
| 2000 Q3 | 1.32 Billion USD | -0.53% |
| 2000 Q2 | 1.33 Billion USD | -0.23% |
| 2000 Q1 | 1.33 Billion USD | -0.67% |
| 1999 Q1 | 1.36 Billion USD | 0.37% |
| 1999 Q2 | 1.32 Billion USD | -3.07% |
| 1999 Q3 | 1.33 Billion USD | 0.3% |
| 1999 Q4 | 1.34 Billion USD | 0.83% |
| 1999 FY | 1.34 Billion USD | -1.61% |
| 1998 Q1 | 1.38 Billion USD | 8.44% |
| 1998 Q3 | 1.31 Billion USD | -1.65% |
| 1998 Q4 | 1.36 Billion USD | 3.81% |
| 1998 FY | 1.36 Billion USD | 6.65% |
| 1998 Q2 | 1.33 Billion USD | -3.68% |
| 1997 Q2 | 971 Million USD | 1.04% |
| 1997 Q4 | 1.27 Billion USD | 1.11% |
| 1997 FY | 1.27 Billion USD | 32.4% |
| 1997 Q1 | 961 Million USD | -0.52% |
| 1997 Q3 | 1.26 Billion USD | 30.28% |
| 1996 Q3 | 626 Million USD | 9.44% |
| 1996 FY | 966 Million USD | 52.13% |
| 1996 Q1 | 626 Million USD | -1.42% |
| 1996 Q2 | 572 Million USD | -8.63% |
| 1996 Q4 | 966 Million USD | 54.31% |
| 1995 FY | 635 Million USD | -1.4% |
| 1995 Q1 | 665 Million USD | 3.26% |
| 1995 Q2 | 679 Million USD | 2.11% |
| 1995 Q3 | 632 Million USD | -6.92% |
| 1995 Q4 | 635 Million USD | 0.47% |
| 1994 Q3 | 639 Million USD | 0.47% |
| 1994 Q4 | 644 Million USD | 0.78% |
| 1994 Q1 | 628 Million USD | 6.8% |
| 1994 Q2 | 636 Million USD | 1.27% |
| 1994 FY | 644 Million USD | 9.52% |
| 1993 Q2 | 601 Million USD | 233.89% |
| 1993 FY | 588 Million USD | 234.09% |
| 1993 Q3 | 604 Million USD | 0.5% |
| 1993 Q4 | 588 Million USD | -2.65% |
| 1993 Q1 | 180 Million USD | 2.27% |
| 1992 Q4 | 176 Million USD | 27.54% |
| 1992 FY | 176 Million USD | 30.37% |
| 1992 Q1 | 132 Million USD | -2.22% |
| 1992 Q2 | 86 Million USD | -34.85% |
| 1992 Q3 | 138 Million USD | 60.47% |
| 1991 FY | 135 Million USD | -41.56% |
| 1991 Q3 | 153 Million USD | -7.83% |
| 1991 Q4 | 135 Million USD | -11.76% |
| 1991 Q1 | 216 Million USD | -6.49% |
| 1991 Q2 | 166 Million USD | -23.15% |
| 1990 Q1 | 232 Million USD | -2.11% |
| 1990 Q2 | 228 Million USD | -1.72% |
| 1990 Q3 | 249 Million USD | 9.21% |
| 1990 Q4 | 231 Million USD | -7.23% |
| 1990 FY | 231 Million USD | -2.53% |
| 1989 FY | 237 Million USD | -16.55% |
| 1989 Q4 | 237 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbbVie Inc. | 52.19 Billion USD | 26.844% |
| Bristol-Myers Squibb Company | 38.18 Billion USD | 0.0% |
| Johnson & Johnson | 25.88 Billion USD | -47.533% |
| Eli Lilly and Company | 18.32 Billion USD | -108.413% |
| Merck & Co., Inc. | 33.68 Billion USD | -13.36% |
| Novartis AG | 20.03 Billion USD | -90.591% |
| Organon & Co. | 8.75 Billion USD | -336.327% |
| Pfizer Inc. | 61.53 Billion USD | 37.952% |